A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors
BeOne Medicines
BeOne Medicines
Eli Lilly and Company
MOMA Therapeutics
Eli Lilly and Company
Wake Forest University Health Sciences
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Eli Lilly and Company
Nammi Therapeutics Inc
National Cancer Institute (NCI)
Beijing Biotech
Parabilis Medicines, Inc.
Exscientia AI Limited
Memorial Sloan Kettering Cancer Center
Conjupro Biotherapeutics, Inc.
Centre hospitalier de l'Université de Montréal (CHUM)
Conjupro Biotherapeutics, Inc.
AstraZeneca
Agenus Inc.
858 Therapeutics, Inc.